0001209191-17-047016.txt : 20170802
0001209191-17-047016.hdr.sgml : 20170802
20170802082117
ACCESSION NUMBER: 0001209191-17-047016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170801
FILED AS OF DATE: 20170802
DATE AS OF CHANGE: 20170802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wills Robert James
CENTRAL INDEX KEY: 0001634189
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36500
FILM NUMBER: 17998443
MAIL ADDRESS:
STREET 1: 175 TOYOTA PLAZA, 7TH FLOOR
CITY: MEMPHIS
STATE: TN
ZIP: 38103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 7999 GATEWAY BLVD
STREET 2: SUITE 130
CITY: NEWARK
STATE: CA
ZIP: 94560
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-08-01
0
0001042074
CymaBay Therapeutics, Inc.
CBAY
0001634189
Wills Robert James
C/O CYMABAY THERAPEUTICS, INC.
7999 GATEWAY BOULEVARD, SUITE 130
NEWARK
CA
94560
1
0
0
0
Common Stock
2017-08-01
4
P
0
200
6.829
A
25200
D
Common Stock
2017-08-01
4
P
0
300
6.838
A
25500
D
Common Stock
2017-08-01
4
P
0
1000
6.839
A
26500
D
Common Stock
2017-08-01
4
P
0
3500
6.847
A
30000
D
/s/ Sujal Shah, Attorney-in-Fact
2017-08-01